ICI-Associated AKI: Suspect AIN, Do Not Assume It

Clinical Mastery · Visual teaching summary · October 3, 2026

Andrew Bland, MD, FACP, FAAP

Visual summary

Do not label every creatinine rise as ICI nephritis or every biopsy pattern as inevitable. The explanation must fit the full clinical picture.

ICI-Associated AKI: Suspect AIN, Do Not Assume It: six-panel learning summary. Full text follows below.
Download infographic (PNG) · Download Markdown · Read text version ·

Text version

Loss of immune restraint

Checkpoint inhibitors can provoke immune-mediated kidney injury. Acute interstitial nephritis is an important pattern, but other causes of AKI remain common.

Review the timeline

Cancer therapy, other immune adverse events, acid suppressants, antibiotics, NSAIDs, dehydration, and infection all inform the differential.

Assess urine and kidney trends

Pyuria, proteinuria, sediment, and creatinine changes are clues. Their absence or presence does not reliably diagnose immune-mediated injury alone.

Consider biopsy when it matters

Tissue can distinguish interstitial, tubular, vascular, and glomerular lesions when uncertainty would change immunosuppression or cancer-treatment decisions.

Coordinate oncology and nephrology

Balance kidney recovery, diagnostic confidence, cancer control, and treatment toxicity. Review unnecessary potential nephritogenic drugs.

Avoid categorical shortcuts

Do not label every creatinine rise as ICI nephritis or every biopsy pattern as inevitable. The explanation must fit the full clinical picture.

Continue learning

This graphic summarizes a topic. The full educational pages provide the broader discussion and references.